Lonza | LONN - Assets


Lonza reported CHF18.97B in Assets for its fiscal semester ending in December of 2025.





Assets Change Date
Akzo Nobel EUR 16.02B 114M Sep/2026
Alcon AG USD 31.1B 521M Jun/2026
Almirall EUR 2.37B 29.97M Jun/2026
AstraZeneca USD 119.92B 4.09B Sep/2026
BASF EUR 79.94B 3.92B Sep/2026
Bayer EUR 113.47B 6.18B Sep/2026
Beiersdorf EUR 13.32B 560M Jun/2026
Covestro EUR 13.88B 408M Jun/2026
Demant DKK 40.03B 951M Jun/2026
Fresenius EUR 42.24B 401M Sep/2026
Fresenius Medical Care EUR 31.45B 155.97M Sep/2026
Geberit CHF 3.86B 252.6M Dec/2025
Genmab DKK 12.52B 139M Jun/2026
Givaudan CHF 11.86B 587M Dec/2025
GlaxoSmithKline GBP 71.7B 9.96B Sep/2026
GN Store Nord DKK 30.31B 762M Sep/2026
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Johnson Matthey GBP 5.97B 142M Jun/2026
Merck EUR 53.66B 975M Sep/2026
Novartis USD 117.15B 4.88B Sep/2026
Philips EUR 28.03B 1.33B Sep/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
Sanofi EUR 130.29B 1.23B Sep/2026
Sika AG CHF 15.15B 245M Dec/2025
Smith & Nephew USD 11.01B 321M Jun/2026
Solvay EUR 6.22B 139M Sep/2026
UCB EUR 18.16B 971M Dec/2025